Literature DB >> 33507363

Can exercise training enhance the repeated remote ischaemic preconditioning stimulus on peripheral and cerebrovascular function in high-risk individuals?

Joseph D Maxwell1, Madeleine France2, Lucy E M Finnigan2, Howard H Carter2,3, Dick H J Thijssen2,4, Helen Jones2.   

Abstract

BACKGROUND: Repeated exposure to remote ischaemic preconditioning (rIPC; short bouts of non-lethal ischaemia) enhances peripheral vascular function within 1 week; whereas, longer periods of rIPC (~ 1 year) may improve cerebral perfusion. Increasing the 'dose' of rIPC may lead to superior effects. Given the similarities between exercise and rIPC, we examined whether adding exercise to the rIPC stimulus leads to greater adaptation in systemic vascular function.
METHODS: Nineteen individuals with increased risk for cardiovascular disease (CVD) were randomly allocated to either 8 weeks of rIPC (n = 9) or 8 weeks of rIPC + exercise (rIPC + Ex) (n = 10). rIPC was applied three times per week in both conditions, and exercise consisted of 50 min (70% heart rate max) of cycling 3 times per week. Peripheral endothelial function was assessed using flow-mediated dilation (FMD) before and after ischaemia-reperfusion (IR). Cerebrovascular function was assessed by dynamic cerebral autoregulation (dCA) and cerebrovascular reactivity (CVR), and cardio-respiratory fitness (VO2peak) using a maximal aerobic capacity test.
RESULTS: FMD% increased by 1.6% (95% CI, 0.4, 2.8) following rIPC + Ex and by 0.3% (- 1.1, 1.5) in the only rIPC but this did not reach statistical significance (P = 0.65). Neither intervention evoked a change in dCA or in CVR (P > 0.05). VO2peak increased by 2.8 ml/kg/min (1.7, 3.9) following the rIPC + Ex and by 0.1 ml/kg/min (- 1.0, 1.4) following the rIPC only intervention (P = 0.69).
CONCLUSION: Combining exercise with rIPC across an 8-week intervention does not lead to superior effects in cerebrovascular and peripheral vascular function compared to a repeated rIPC intervention in individuals at risk of CVD.

Entities:  

Keywords:  Cardiovascular disease; Cerebral autoregulation; Exercise; Remote ischaemic preconditioning; Vascular function

Year:  2021        PMID: 33507363      PMCID: PMC7966185          DOI: 10.1007/s00421-020-04580-6

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN: 1439-6319            Impact factor:   3.078


  54 in total

1.  Cerebral blood flow and cerebrovascular reactivity at rest and during sub-maximal exercise: effect of age and 12-week exercise training.

Authors:  Carissa J Murrell; James D Cotter; Kate N Thomas; Samuel J E Lucas; Michael J A Williams; Philip N Ainslie
Journal:  Age (Dordr)       Date:  2012-06-06

Review 2.  Mechanoreception by the endothelium: mediators and mechanisms of pressure- and flow-induced vascular responses.

Authors:  G M Rubanyi; A D Freay; K Kauser; A Johns; D R Harder
Journal:  Blood Vessels       Date:  1990

3.  Exercise training improves cutaneous microvascular function in nonalcoholic fatty liver disease.

Authors:  Christopher J A Pugh; Daniel J Cuthbertson; Victoria S Sprung; Graham J Kemp; Paul Richardson; A Margot Umpleby; Daniel J Green; N Timothy Cable; Helen Jones
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-05-07       Impact factor: 4.310

4.  Expert consensus and evidence-based recommendations for the assessment of flow-mediated dilation in humans.

Authors:  Dick H J Thijssen; Rosa Maria Bruno; Anke C C M van Mil; Sophie M Holder; Francesco Faita; Arno Greyling; Peter L Zock; Stefano Taddei; John E Deanfield; Thomas Luscher; Daniel J Green; Lorenzo Ghiadoni
Journal:  Eur Heart J       Date:  2019-08-07       Impact factor: 29.983

5.  Cognitive functions in severe congestive heart failure before and after an exercise training program.

Authors:  David Tanne; Dov Freimark; Amir Poreh; Oleg Merzeliak; Bella Bruck; Yvonne Schwammenthal; Ehud Schwammenthal; Michael Motro; Yehuda Adler
Journal:  Int J Cardiol       Date:  2005-01-12       Impact factor: 4.164

6.  Heart failure is associated with exaggerated endothelial ischaemia-reperfusion injury and attenuated effect of ischaemic preconditioning.

Authors:  Joost P H Seeger; Nathalie M M Benda; Niels P Riksen; Arie P J van Dijk; Louise Bellersen; Maria T E Hopman; N Timothy Cable; Dick H J Thijssen
Journal:  Eur J Prev Cardiol       Date:  2014-11-11       Impact factor: 7.804

7.  Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion.

Authors:  K Przyklenk; B Bauer; M Ovize; R A Kloner; P Whittaker
Journal:  Circulation       Date:  1993-03       Impact factor: 29.690

Review 8.  Repeated ischaemic preconditioning: a novel therapeutic intervention and potential underlying mechanisms.

Authors:  Dick H J Thijssen; Joseph Maxwell; Daniel J Green; N Timothy Cable; Helen Jones
Journal:  Exp Physiol       Date:  2016-06-01       Impact factor: 2.969

9.  Ischemic Conditioning Is Safe and Effective for Octo- and Nonagenarians in Stroke Prevention and Treatment.

Authors:  Ran Meng; Yuchuan Ding; Karam Asmaro; David Brogan; Lu Meng; Meng Sui; Jingfei Shi; Yunxia Duan; Zhishan Sun; Yang Yu; Jianping Jia; Xunming Ji
Journal:  Neurotherapeutics       Date:  2015-07       Impact factor: 7.620

Review 10.  Exercise modalities and endothelial function: a systematic review and dose-response meta-analysis of randomized controlled trials.

Authors:  Ammar W Ashor; Jose Lara; Mario Siervo; Carlos Celis-Morales; Clio Oggioni; Djordje G Jakovljevic; John C Mathers
Journal:  Sports Med       Date:  2015-02       Impact factor: 11.136

View more
  2 in total

1.  Effects of the Training of Aerobic Function on Clinical Symptoms and Quality of Life in Patients with Medium and Advanced Lung Cancer.

Authors:  Xiangyan Lv; Yan Zhao; Yuqin Wu
Journal:  J Healthc Eng       Date:  2022-03-23       Impact factor: 2.682

Review 2.  Remote ischaemic preconditioning - translating cardiovascular benefits to humans.

Authors:  James A Lang; Jahyun Kim
Journal:  J Physiol       Date:  2022-05-31       Impact factor: 6.228

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.